Advertisement

The Hemostatic Mechanism in Pregnancy, Labor and the Puerperium

  • Derek Ogston

Abstract

Pregnancy is accompanied by widespread maternal physiological changes involving most systems of the body; these represent adaptations appropriate to the provision of a suitable environment for the developing fetus and the facilitation of childbirth. The hemostatic mechanism also responds to the stimulus of pregnancy, although the precise function of the changes produced is more speculative. The mediation of the maternal responses to pregnancy are presumably hormonal: during the last half of pregnancy large quantities of estrogen and progesterone are produced by the placenta, but detailed information on the relationship of these to the hemostatic changes is lacking.

Keywords

Factor VIII Fibrinolytic Activity Factor Xiii Coagulant Activity Plasma Protein Fraction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander, B., Meyers, L., Kenny, J., Goldstein, R., Gurewich, V. and Grinspaan, L. (1956) ‘Blood coagulation in pregnancy. Proconvertin and prothrombin, and the hypercoagulable state’, New England Journal of Medicine, 254, 358–63CrossRefGoogle Scholar
  2. Amir, J., Pensky, J. and Ratnoff, O.D. (1972) ‘Plasma inhibition of activated plasma thromboplastin antecedent (factor Xla) in pregnancy’, Journal of Laboratory and Clinical Medicine, 79, 106–12Google Scholar
  3. Arias, F., Andrinopoulos, G. and Zamora, J. (1979) ‘Whole-blood fibrinolytic activity in normal and hypertensive pregnancies and its relation to the placental concentration of urokinase inhibitor’, American Journal of Obstetrics and Gynecology, 133, 624–9Google Scholar
  4. Astedt, B. (1972) ‘On fibrinolysis’, Acta Obstetrica et Gynaecologica, Suppl. 18Google Scholar
  5. Astedt, B., Isacson, S., Nilsson, I.M. and Pandolfi, M. (1970) ‘Fibrinolytic activity of veins during pregnancy’, Acta Obstetrica et Gynaecologica, 49, 171–3CrossRefGoogle Scholar
  6. Bennett, B. and Ratnoff, O.D. (1972) ‘Antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in normal pregnancy, and following exercise and pneumoencephalography’, Journal of Laboratory and Clinical Medicine, 80, 256–63Google Scholar
  7. Bennett, B., Oxnard, S.C, Douglas, A.S. and Ratnoff, O.D. (1974) ‘Studies on antihemophilic factor (AHF, factor VIII) during labor in normal women, in patients with premature separation of the placenta, and in a patient with von Willebrand’s disease’, Journal of Laboratory and Clinical Medicine, 84, 851–60Google Scholar
  8. Biezenski, J.J. (1960) ‘Antifibrinolytic activity in normal pregnancy’, Journal of Clinical Pathology, 13, 220–3CrossRefGoogle Scholar
  9. Biezenski, J.J. and Moore, H.C. (1958) ‘Fibrinolysis in normal pregnancy’, Journal of Clinical Pathology, 11, 306–10CrossRefGoogle Scholar
  10. Biland, L. and Duckert, F. (1973) ‘Coagulation factors of the newborn and his mother’, Thrombosis et Diathesis Haemorrhagica, 29, 644–51Google Scholar
  11. Bonnar, J. (1976) ‘Coagulation disorders’, Journal of Clinical Pathology, 29, Suppl. 10, 35–41CrossRefGoogle Scholar
  12. Bonnar, J. (1978) ‘Fibrinolysis in human pregnancy’, in P.J. Gaffney and S. Balkuv-Ulutin (eds.) Fibrinolysis. Current Fundamental and Clinical Concepts, Academic Press, London, pp. 173–86Google Scholar
  13. Bonnar, J., McNicol, G.P. and Douglas, A.S. (1969a) ‘Fibrinolytic enzyme system and pregnancy’, British Medical Journal, 3, 387–9CrossRefGoogle Scholar
  14. Bonnar, J., Davidson, J.F., Pidgeon, C.F., McNicol, G.P. and Douglas, A.S. (1969b) ‘Fibrin degradation products in normal and abnormal pregnancy and parturition’, British Medical Journal, 3, 137–40CrossRefGoogle Scholar
  15. Bonnar, J., McNicol, G.P. and Douglas, A.S. (1970a) ‘Coagulation and fibrinolytic mechanisms during and after normal childbirth’, British Medical Journal, 2, 200–3CrossRefGoogle Scholar
  16. Bonnar, J., Prentice, C.R.M., McNicol, G.P. and Douglas, A.S. (1970b) ‘Haemostatic mechanism in the uterine circulation’, British Medical Journal, 2, 564–7CrossRefGoogle Scholar
  17. Brakman, P. (1966) ‘The fibrinolytic system in human blood during pregnancy’, American Journal of Obstectrics and Gynecology, 94, 14–20Google Scholar
  18. Brakman, P. and Astrup, T. (1963) ‘Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis’, Scandinavian Journal of Clinical and Laboratory Investigation, 15, 603–9CrossRefGoogle Scholar
  19. Campbell, D.M., Ogston, D. and Walker, J.E. (1980) ‘The inhibition of urokinase and tissue plasminogen activator by human pregnancy plasma’, Journal of Physiology, 303, 44–58Google Scholar
  20. Clemmensen, I., Thorsen, S. and Mullertz, S. (1976) ‘Purification of a plasminogen activator inhibitor indistinguishable from a!-antitrypsin and an urokinase inhibitor in pregnancy plasma’, Haemostasis, 5, 218–30Google Scholar
  21. Condie, R.G. and Ogston, D. (1976) ‘Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of preeclampsia’, Journal of Obstetrics and Gynaecology of the British Commonwealth, 83, 938–42CrossRefGoogle Scholar
  22. Coopland, A., Alkjaersig, N. and Fletcher, A.P. (1969) ‘Reduction in plasma factor XIII (fibrin stabilising factor) concentration during pregnancy’, Journal of Laboratory and Clinical Medicine, 73, 144–53Google Scholar
  23. Donaldson, V.H. (1966) ‘Serum inhibitor of Cl-esterase in health and disease’, Journal of Laboratory and Clinical Medicine, 68, 369–82Google Scholar
  24. Ebert Ch., Berg, H. and Zimmermann, R.E. (1981) ‘The hormone-dependent concentration changes of factor XIII (fibrinoligase) during pregnancy’, Thrombosis and Haemostasis, 46, 345Google Scholar
  25. Fenton, V., Saunders, K. and Cavill, I. (1977) ‘The platelet count in pregnancy’, Journal of Clinical Pathology, 30, 68–9CrossRefGoogle Scholar
  26. Fletcher, A.P., Alkjaersig, N.K. and Burstein, R. (1979) ‘The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme function’, American Journal of Obstetrics and Gynecology, 134, 743–51Google Scholar
  27. Fournie, A., Monrozies, M., Pontonnier, G., Boneu, B. and Bierme, R. (1981) ‘Factor VIII complex in normal pregnancy, pre-eclampsia and foetal growth retardation’, British Journal of Obstetrics and Gynaecology, 88, 250–4CrossRefGoogle Scholar
  28. Fresh, J.W., Adams, H. and Morgan, F.M. (1959) ‘Vitamin K-blood clotting studies during pregnancy and prothrombin and proconvertin levels in the newborn’, Obstetrics and Gynecology, 13, 37–40Google Scholar
  29. Ganrot, P.O. and Bjerre, B. (1967) ‘A antitrypsin and oc2-macroglobulin concentration in serum during pregnancy’, Acta Obstetricla et Gynaecologica Scandinavica, 46, 126–37Google Scholar
  30. Gilabert, J., Aznar, J., Parrilla, J.J., Reganon, E., Vila, V. and Estelles, A. (1978) ‘Alteration in the coagulation and fibrinolysis system in pregnancy, labour and puerperium, with special reference to a possible transitory state of intravascular coagulation during labour’, Thrombosis and Haemostasis, 40, 387–96Google Scholar
  31. Gillman, T., Naidoo, S.S. and Hathorn, M. (1959) ‘Plasma fibrinogen activity in pregnancy’, Lancet, ii, 70–1Google Scholar
  32. Gjesdal, K. (1974) ‘Platelet factor 4 (PF-4). A study in methodology and physiology’, Scandinavian Journal of Haematology, 12, 51–9CrossRefGoogle Scholar
  33. Gjonnaess, H., Fagerhol, M.K. and Stormorken, H. (1975) ‘Studies on coagulation and fibrinolysis in blood from puerperal women with and without oestrogen treatment’, British Journal of Obstetrics and Gynaecology, 82, 151–7CrossRefGoogle Scholar
  34. Gordon, Y.B., Ratky, S.M., Sola, CM., Lewis, J., Baker, L.R.I, and Chard, T. (1975) ‘Circulating levels of fibrin/fibrinogen degradation fragment E in normal pregnancy, and in association with intrauterine growth retardation and perinatal asphyxia’, British Journal of Obstetrics and Gynaecology, 82, 958–63CrossRefGoogle Scholar
  35. Graeff, H., von Hugo, R. and Hafter, R. (1973) 7/t vivo formation of soluble fibrin monomer complexes in human plasma’, Thrombosis Research, 3, 465–76Google Scholar
  36. Graeff, H., Wiedemann, A., von Hugo, R. and Hafter, R. (1976) ‘Amount and distribution patterns of soluble fibrin monomer complexes during the early Puerperium’, American Journal of Obstetrics and Gynecology, 124, 21–4Google Scholar
  37. Guest, M.M. (1954) ‘Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject’, Journal of Clinical Investigation, 33, 1553–9CrossRefGoogle Scholar
  38. Hahn, L. (1974) ‘On fibrinolysis and coagulation during parturition and menstruation’, Acta Obstetrica et Gynaecologica Scandinavica, Suppl. 28Google Scholar
  39. Hathaway, W.E. and Bonnar, J. (1978) Perinatal Coagulation, Grune and Stratton, New York, p. 38Google Scholar
  40. Hedner, U. and Astedt, B. (1970) ‘Fibrinolytic split products in serum and urine in pregnancy’, Acta Obstetrica et Gynaecologica Scandinavica, 49, 363–6CrossRefGoogle Scholar
  41. Hedner, U. and Astedt, B. (1971) ‘Studies on fibrinolytic inhibitors during pregnancy’, Acta Obstetrica et Gynaecologica Scandinavica, 50, 99–103CrossRefGoogle Scholar
  42. Hedner, U. and Nilsson, I.M. (1965) ‘Determination of plasminogen in human plasma by a casein method’, Thrombosis et Diathesis Haemorrhagica, 14, 545–61Google Scholar
  43. Hilgartner, M.W. and Smith, CH. (1965) ‘Plasma thromboplastin antecedent (factor XI) in the neonate’, Journal of Pediatrics, 66, 747–52CrossRefGoogle Scholar
  44. Hyde, E., Joyce, D., Gurewich, V. and Flute, P.T. (1973) ‘Intravascular coagulation during pregnancy and the puerperium’, Journal of Obstetrics and Gynaecology of the British Commonwealth, 80, 1059–66CrossRefGoogle Scholar
  45. Inglis, T.C.M., Stuart, J., George, A.J. and Davies, A.J. (1982) ‘Haemostatic and rheological changes in normal pregnancy and pre-eclampsia’, British Journal of Haematology, 50, 461–5CrossRefGoogle Scholar
  46. Johansen, K.A., Williams, J.H. and Stark, J.M. (1981) ‘Acute-phase C 56- forming ability and concentrations of complement components in normotensive and hypertensive pregnancies’, British Journal of Obstetrics and Gynaecology, 88, 504–12CrossRefGoogle Scholar
  47. Kasper, C.K., Hoag, M.S., Aggeler, P.M. and Stone, S. (1964) ‘Blood clotting factors in pregnancy: factor VIII concentrations in normal and AHF-deficient women’, Obstetrics and Gynecology, 24, 242–7Google Scholar
  48. Kawano, T., Morimoto, K. and Uemura, Y. (1968) ‘Urokinase inhibitor in human placenta’, Nature, 217, 253–4CrossRefGoogle Scholar
  49. Kennan, A.L. and Bell, W.B. (1957) ‘Blood coagulation during normal pregnancy, labor and the puerperium’, American Journal of Obstetrics and Gynecology, 73, 57–64Google Scholar
  50. Kleiner, G.J., Merskey, C, Johnson, A.J. and Marcus, W.B. (1970) ‘Defibrination in normal and abnormal parturition’, British Journal of Haematology, 19, 159–78CrossRefGoogle Scholar
  51. Lewis, P.J., Boylan, P., Friedman, L.A., Hensby, CN. and Downing, I. (1980) ‘Prostacyclin in pregnancy’, British Medical Journal, 3, 1581–2CrossRefGoogle Scholar
  52. McKillop, C, Howie, P.W., Forbes, CD. and Prentice, C.R.M. (1976) ‘Soluble fibrinogen/fibrin complexes in pre-eclampsia’, Lancet, i, 56–8CrossRefGoogle Scholar
  53. Menon, I.S., Rannie, G.H. and Dewar, H.A. (1970) ‘A comparative study of blood fibrinolytic activity in normal women, pregnant women and women on oral contraceptives’, Journal of Obstetrics and Gynaecology of the British Commonwealth, 77, 752–6CrossRefGoogle Scholar
  54. Mitchell, P. and Cope, I. (1965) ‘The estimation of plasminogen in human serum or plasma’, Clinica Chimica Acta, 11, 414–23CrossRefGoogle Scholar
  55. Mor, A., Yang, W., Schwarz, A. and Jones, W.C. (1960) ‘Platelet counts in pregnancy and labour’, Obstetrics and Gynecology, 16, 338–43Google Scholar
  56. Naish, P., Clark, A.D., Winston, R.M.L. and Peters, D.K. (1973) ‘Serum and urine fibrinogen derivatives in normal pregnancy and pre-eclampsia’, Obstetrics and Gynecology, 42, 861–7Google Scholar
  57. Nilsson, I.M. and Kullander, S. (1967) ‘Coagulation and fibrinolytic studies during pregnancy’, Acta Obstetricia et Gynaecologica Scandinavica, 46, 273–85CrossRefGoogle Scholar
  58. Nossel, H.L., Lanzkowsky, P. and Levy, S. (1966) ‘A study of coagulation factor levels in women during labour and in their newborn infants’, Thrombosis et Diathesis Haemorrhagica, 16, 185–97Google Scholar
  59. O’Brien, J.R. (1976) ‘Platelet counts in normal pregnancy’, Journal of Clinical Pathology, 29, 174CrossRefGoogle Scholar
  60. Ogston, D., Walker, J. and Campbell, D.M. (1981) ‘CI inactivator level in pregnancy’, Thrombosis Research, 23, 453–5CrossRefGoogle Scholar
  61. Padar, E. (1972) ‘Fibrin cross-linkage, thrombosis and pregnancy’, Annals of the New York Academy of Sciences, 202, 230–4CrossRefGoogle Scholar
  62. Pechet, L. and Alexander, B. (1961) ‘Increased clotting factors in pregnancy’, New England Journal of Medicine, 265, 1093–7CrossRefGoogle Scholar
  63. Phillips, L.L. and Skrodelis, V. (1958) ‘The fibrinolytic enzyme system in normal, hemorrhagic and disease states’, Journal of Clinical Investigation, 37, 965–73CrossRefGoogle Scholar
  64. Phillips, L.L., Rosano, L. and Skrodelis, V. (1973) ‘Changes in factor XI (plasma thromboplastin antecedent) levels during pregnancy’, American Journal of Obstetrics and Gynecology, 116, 1114–6Google Scholar
  65. Plass, E.D. and Matthew, C.W. (1926) ‘Plasma protein fractions in normal pregnancy, labour and puerperium’, American Journal of Obstetrics and Gynecology, 12, 346–58Google Scholar
  66. Räköczi, I., Talliän, F., Bagdäny, S. and Gäti, I. (1979) ‘Platelet life-span innormal pregnancy and pre-eclampsia as determined by a non-radiographic technique’, Thrombosis Research, 15, 553–6CrossRefGoogle Scholar
  67. Ratnoff, O.D. and Holland, T.R. (1959) Coagulation components in normal and abnormal pregnancies, Annals of the New York Academy of Sciences, 75, 626–33CrossRefGoogle Scholar
  68. Ratnoff, O.D., Colopy, B.S. and Pritchard, J.A. (1954) ‘The blood clotting mechanism during normal parturition’, Journal of Laboratory and Clinical Medicine, 44, 408–15Google Scholar
  69. Redman, C.W.G., Bonnar, J. and Beilin, L. (1978) ‘Early platelet consumption in preeclampsia’, British Medical Journal, 1, 467–9CrossRefGoogle Scholar
  70. Regoeczi, E. and Hobbs, K.R. (1969) ‘Fibrinogen turnover in pregnancy’, Scandinavian Journal of Haematology, 6, 175–8CrossRefGoogle Scholar
  71. Ross, R.A. (1963) ‘Blood coagulation defects in obstetrics and gynecology’, American Journal of Obstetrics and Gynecology, 86, 77–84Google Scholar
  72. Rutherford, R.N., Hougie, C, Banks, A.L. and Coburn, W.A. (1964) ‘The effects of sex steroids and pregnancy on blood coagulation factors’, Obstetrics and Gynecology, 24, 886–92Google Scholar
  73. Sanderson, J.H., Taylor, D.S. and Delamore, I.W. (1973) ‘Changes in platelet thrombotic tendency during parturition’, Journal of Obstectrics and Gynaecology of the British Commonwealth, 80, 633–8CrossRefGoogle Scholar
  74. Sejeney, S.A., Eastham, R.D. and Baker, S.R. (1975) ‘Platelet counts during normal pregnancy’, Journal of Clinical Pathology, 28, 812–3CrossRefGoogle Scholar
  75. Shaper, A.G., Kear, J., Macintosh, D.M., Kyobe, J. and Njama, D. (1968) ‘The count, platelet adhesiveness and aggregation and the mechanism of fibrinolytic inhibition in pregnancy and the puerperium’, British Journal of Obstetrics and Gynaecology of the British Commonwealth, 75, 433–41CrossRefGoogle Scholar
  76. Shaper, A.G., Macintosh, D.M., Evans, CM. and Kyobe, J. (1965) ‘Fibrinolysis and plasminogen levels in pregnancy and the puerperium’, Lancet, ii, 706–8CrossRefGoogle Scholar
  77. Shaper, A.G., Macintosh, D.M. and Kyobe, J. (1966) ‘Fibrinolytic activity in pregnancy, during parturition, and in the puerperium’, Lancet, ii, 874–6CrossRefGoogle Scholar
  78. Sheppard, B.L. and Bonnar, J. (1974) ‘The ultrastructure of the arterial supply of the human placenta in early and late pregnancy’, Journal of Obstetrics and Gynaecology of the British Commonwealth, 81, 497–511CrossRefGoogle Scholar
  79. Sheppard, B.L. and Bonnar, J. (1978) ‘Fibrinolysis in decidual spiral arteries in late pregnancy’, Thrombosis et Diathesis Haemorrhagica, 39, 751–8Google Scholar
  80. Stiehm, E.R., Kennan, A.L. and Schelble, D.T. (1970) ‘Split products of fibrin in maternal serum in the perinatal period’, American Journal of Obstetrics and Gynecology, 108, 941–5Google Scholar
  81. Strauss, H.S. and Diamond, L.K. (1963) ‘Elevation of factor VIII (antihemophilic factor) during pregnancy in normal persons and in a patient with von Willebrand’s disease’, New England Journal of Medicine, 269, 1251–2CrossRefGoogle Scholar
  82. Talbert, L.M. and Langdell, R.D. (1964) ‘Normal values of certain factors in the blood clotting mechanism in pregnancy’, American Journal of Obstetrics and Gynecology, 90, 44–9Google Scholar
  83. Teger-Nilsson, A.-C. (1979) ‘Use of chromogenic substrates for screening of inhibitors of coagulation and fibrinolysis in patients’, in M.F. Scully and V.V. Kakkar (eds.) Chromogenic Peptide Substrates: Chemistry and Clinical Usage, Churchill Livingstone, Edinburgh, pp. 269–76Google Scholar
  84. Thorsen, S. (1973) ‘The inhibition of tissue plasminogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects’, Scandinavian Journal of Clinical and Laboratory Investigation, 31, 51–9CrossRefGoogle Scholar
  85. Todd, M.E., Thompson, J.H., Bowie, E.J.W. and Owen, C.A. (1965) ‘Changes in blood coagulation during pregnancy’, Mayo Clinics Proceedings, 40, 370–83Google Scholar
  86. Uszynski, M. and Abildgaard, U. (1971) ‘Separation and characterization of two fibrinolytic inhibitors from human placenta’, Thrombosis et Diathesis Haemorrhagica, 25, 580–9Google Scholar
  87. Uszynski, M. and Uszynska-Folejewska, R. (1967) ‘The plasminogen activator content of the myometrium in nonpregnant, pregnant, and parturient women’, American Journal of Obstetrics and Gynecology, 98, 825–31Google Scholar
  88. Van Royen, E.A. and Ten Cate, J.W. (1973) ‘Antigen-biological activity ratio for factor VIII in late pregnancy’, Lancet, ii, 449–50Google Scholar
  89. Walker, J.E., Campbell, D.M. and Ogston, D. (1982) ‘Blood levels of proteinase inhibitors in pregnancy’, British Journal of Obstetrics and Gynaecology, 89, 208–10CrossRefGoogle Scholar
  90. Wallenburg, H.C.S. and van Kessel, P.H. (1978) ‘Platelet lifespan in normal pregnancy as determined by a nonradioisotopic technique’, British Journal of Obstetrics and Gynaecology, 85, 33–6CrossRefGoogle Scholar
  91. Ward, CV. and MacArthur, J.L. (1948) ‘Blood platelet studies during pregnancy and the puerperium’, American Journal of Obstetrics and Gynecology, 55, 600–7Google Scholar
  92. Whigham, K.A.E., Howie, P.W., Drummond, A.H. and Prentice, C.R.M. (1978) ‘Abnormal platelet function in pre-eclampsia’, British Journal of Obstetrics and Gynaecology, 85, 28–32CrossRefGoogle Scholar
  93. Woodfield, D.G., Cole, S.K. and Cash, J.D. (1968) ‘Impaired fibrinolytic response to exercise stress in normal pregnancy’, American Journal of Obstetrics and Gynecology, 102, 440–6Google Scholar
  94. Wright, H.P. (1942) ‘Changes in the adhesiveness of blood platelets following parturition and surgical operation’, Journal of Pathology and Bacteriology, 54, 461–8CrossRefGoogle Scholar
  95. Yamazaki, H., Motomiya, T., Kitutani, N., Sakakihara, C, Watanabe, S., Numata, M. and Noguchi, K. (1979) ‘Platelet aggregation during menstrual cycle and pregnancy’, Thrombosis Research, 14, 333–40CrossRefGoogle Scholar
  96. Ygge, J. (1969) ‘Changes in blood coagulation and fibrinolysis during the Puerperium’, American Journal of Obstetrics and Gynecology, 104, 2–12Google Scholar
  97. Ylikorkala, O. and Viinikka, L. (1980) ‘Thromboxane A2 in pregnancy and Puerperium’, British Medical Journal 4, 1601–2CrossRefGoogle Scholar

Copyright information

© Derek Ogston 1983

Authors and Affiliations

  • Derek Ogston
    • 1
  1. 1.University of AberdeenUK

Personalised recommendations